Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Researchers identify new target that may lead to novel treatment for Alzheimer’s disease

Researchers at the Case Western Reserve University School of Medicine have identified a new target in development of Alzheimer's disease (AD) that could lead to therapies focused on treating the neurodegenerative condition early in its progression.

7 Dec 2020

Researchers recommend strategies for improving the accuracy of polygenic risk scores

As the consumer genetics industry rapidly expands, more and more people are turning to DNA-based services to learn their risk of developing a wide range of diseases.

5 Dec 2020

Biochemical cascade in the brain leads to the destruction of synapses in Alzheimer's

A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.

5 Dec 2020

A new potential therapy for Alzheimer's disease

A new potential therapeutic target for Alzheimer’s disease has been discovered by US researchers based at Case Western Reserve University.

4 Dec 2020

Experts address the global burden of brain diseases

Think Brain Health - a policy, clinical and research challenge, a virtual meeting featuring expert speakers in the field of neurodegenerative diseases, addressed current and future opportunities to help everyone achieve good brain health.

3 Dec 2020

Three leading organizations join hands to address global challenges in dementia

To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects as part of this year's Pilot Awards for Global Brain Health Leaders.

1 Dec 2020

Study may help to better understand the pathological process involved in brain diseases

A team of researchers at the Case Western Reserve University School of Medicine has taken a major step toward understanding the mechanisms involved in the formation of large clumps of tau protein, a hallmark of Alzheimer's disease and several other neurodegenerative disorders.

1 Dec 2020

Experimental drug can reverse age-related memory decline in mice

Just a few doses of an experimental drug can reverse age-related declines in memory and mental flexibility in mice, according to a new study by UC San Francisco scientists.

1 Dec 2020

Children with dyslexia show higher emotional reactivity

Children diagnosed with dyslexia show greater emotional reactivity than children without dyslexia, according to a new collaborative study by UC San Francisco neuroscientists with the UCSF Dyslexia Center and UCSF Memory and Aging Center.

1 Dec 2020

FAU receives $675,000 grant to improve social engagement in older population

Vibrant social relationships are a critical component of healthy aging. Strong relationships provide emotional support and well-being, promote brain health, and can even slow the progression of neurodegenerative diseases.

1 Dec 2020

Financial symptoms could be used as early predictors of dementia

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to miss payments on bills as early as six years before a clinical diagnosis.

30 Nov 2020

Validated biomarkers can reveal individual’s risk of developing Alzheimer’s

A new study from Lund University in Sweden shows that validated biomarkers can reveal an individual's risk of developing Alzheimer's disease.

30 Nov 2020

Machine learning model uses retinal scans to detect Alzheimer’s disease

A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the approach could one day be used as a predictive tool, according to an interdisciplinary study from Duke University.

30 Nov 2020

Scientists develop new tools to detect very early changes in Alzheimer’s disease

Researchers at the University of Gothenburg in Sweden, together with their colleagues at the Barcelona Beta Research Centre in Spain, the University Medical Centre in Ljubljana, Slovenia, and the University of Paris, have found new forms of tau protein that become abnormal in the very early stages of Alzheimer's disease before cognitive problems develop.

30 Nov 2020

Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases

A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer's disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.

25 Nov 2020

Copper isotopes can help detect Alzheimer's aggregates in the brain

A proof-of-concept study conducted in a mouse model of Alzheimer's disease offers new evidence that copper isotopes can be used to detect the amyloid-beta protein deposits that form in the brains of people living with - or at risk of developing - Alzheimer's.

25 Nov 2020

New drug lures stem cells to damaged tissue, improves treatment efficacy

Scientists at Sanford Burnham Prebys Medical Discovery Institute have created a drug that can lure stem cells to damaged tissue and improve treatment efficacy--a scientific first and major advance for the field of regenerative medicine.

25 Nov 2020

Widely used antibiotic shows promise for fighting against Zika infections

In 2015, hundreds of children were born with brain deformities resulting from a global outbreak of Zika virus infections.

24 Nov 2020

Cerebrospinal fluid may play underappreciated role in both good health and response to injury

Swelling is one of the most dangerous and immediate consequences of a brain injury or stroke. Doctors have long known about the dangers of swelling, which has traditionally been blamed on ruptured blood vessels.

24 Nov 2020

New link found between Alzheimer's dementia and Dlgap2 gene

A gene known for helping facilitate communication between neurons in the nervous system has been discovered to be connected with Alzheimer's dementia and cognitive decline, according to a national research team led by The Jackson Laboratory and University of Maine.

23 Nov 2020

Alzheimer's Disease News and Research

Further Reading

Researchers identify new target that may lead to novel treatment for Alzheimer’s disease

Researchers recommend strategies for improving the accuracy of polygenic risk scores

Biochemical cascade in the brain leads to the destruction of synapses in Alzheimer's

A new potential therapy for Alzheimer's disease

Experts address the global burden of brain diseases

Three leading organizations join hands to address global challenges in dementia

Study may help to better understand the pathological process involved in brain diseases

Experimental drug can reverse age-related memory decline in mice

Children with dyslexia show higher emotional reactivity

FAU receives $675,000 grant to improve social engagement in older population

Financial symptoms could be used as early predictors of dementia

Validated biomarkers can reveal individual’s risk of developing Alzheimer’s

Machine learning model uses retinal scans to detect Alzheimer’s disease

Scientists develop new tools to detect very early changes in Alzheimer’s disease

Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases

Copper isotopes can help detect Alzheimer's aggregates in the brain

New drug lures stem cells to damaged tissue, improves treatment efficacy

Widely used antibiotic shows promise for fighting against Zika infections

Cerebrospinal fluid may play underappreciated role in both good health and response to injury

New link found between Alzheimer's dementia and Dlgap2 gene

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News